Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Assets (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) reported Non-Current Assets of $15.96 million for Q2 2026, up 346.6% from $3.57 million a year earlier and up 273.6% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Viridian Therapeutics, Inc.\DE posted Non-Current Assets of $5.19 million, up 31.5% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of 25.8% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $3.94 million in FY2024 (-0.1%), $3.95 million in FY2023 (+0.7%), $3.92 million in FY2022 (+10.5%) and $3.55 million in FY2021 (+115.7%).
- The Q2 2026 figure ranks as the highest quarterly Non-Current Assets in data going back to Q4 2013.
- Year over year, Non-Current Assets has now increased in each of the last four quarters, with growth averaging 49.3% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q2 2026 (growth of 346.6%); the low point was Q2 2024 (a decline of 22.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.27 million (Q1 2026), $5.19 million (Q4 2025) and $5.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.46 Bn | 1,136.04 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 648.48 Bn | 568.34 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.76 Bn | 476.87 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.34 Bn | 320.72 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 303.12 Bn | 267.11 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 268.74 Bn | 242.43 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 242.66 Bn | 198.06 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 195.34 Bn | 169.53 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.41 Bn | -695.43 Mn | - | 15.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.96 Mn |
| Mar 31, 2026 | 4.27 Mn |
| Dec 31, 2025 | 5.19 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 3.57 Mn |
| Mar 31, 2025 | 3.74 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 3.56 Mn |
| Dec 31, 2023 | 3.95 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 4.04 Mn |
| Dec 31, 2022 | 3.92 Mn |
| Sep 30, 2022 | 3.23 Mn |
| Jun 30, 2022 | 3.66 Mn |
| Mar 31, 2022 | 3.78 Mn |
| Dec 31, 2021 | 3.55 Mn |
| Sep 30, 2021 | 3.27 Mn |
API Access
Viridian Therapeutics, Inc.\DE Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();